{
    "Info": {
        "title": "AIRR Data File",
        "description": "AIRR Data File written by AIRR Standards Python Library",
        "version": 1.4,
        "contact": {
            "name": "AIRR Community",
            "url": "https://github.com/airr-community"
        },
        "license": {
            "name": "Creative Commons Attribution 4.0 International",
            "url": "https://creativecommons.org/licenses/by/4.0/"
        }
    },
    "Repertoire": [
        {
            "repertoire_id": "su001_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su001",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab, Vismodegib",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su001_post_su001_pre1_su001_pre2",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "arm skin",
                        "id": "UBERON:0002427"
                    },
                    "anatomic_site": "arm",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 8323978,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 9158,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su001"
        },
        {
            "repertoire_id": "su002_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su002",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su002_post_su002_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "nose skin",
                        "id": "UBERON:0015476"
                    },
                    "anatomic_site": "nose",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 620,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 456,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su002"
        },
        {
            "repertoire_id": "su003_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su003",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su003_post_su003_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of body",
                        "id": "UBERON:0002097"
                    },
                    "anatomic_site": "chest_arm",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 16243,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 374,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su003"
        },
        {
            "repertoire_id": "su004_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su004",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": null,
                        "immunogen": null,
                        "intervention": "Cemiplimab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su004_post_su004_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of knee",
                        "id": "UBERON:0001510"
                    },
                    "anatomic_site": "knee",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 381,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 1532,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su004"
        },
        {
            "repertoire_id": "su005_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su005",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su005_post_su005_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of external ear",
                        "id": "UBERON:0001459"
                    },
                    "anatomic_site": "ear",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 1050,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 9396,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su005"
        },
        {
            "repertoire_id": "su006_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su006",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab, Vismodegib",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su006_post_su006_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of neck",
                        "id": "UBERON:0001417"
                    },
                    "anatomic_site": "neck",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 210,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 8008,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su006"
        },
        {
            "repertoire_id": "su007_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su007",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su007_post_su007_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of cheek",
                        "id": "UBERON:0008803"
                    },
                    "anatomic_site": "cheek",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 603,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 2482,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su007"
        },
        {
            "repertoire_id": "su008_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su008",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Pembrolizumab, Vismodegib",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su008_post_su008_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "arm skin",
                        "id": "UBERON:0002427"
                    },
                    "anatomic_site": "arm",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 4391,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 8512,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su008"
        },
        {
            "repertoire_id": "su009_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su009",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Sonidegib",
                        "immunogen": null,
                        "intervention": "Cemiplimab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su009_post_su009_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of forehead",
                        "id": "UBERON:0016475"
                    },
                    "anatomic_site": "forehead",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 210,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 15724,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su009"
        },
        {
            "repertoire_id": "su010_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su010",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "carcinoma",
                            "id": "DOID:305"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": null,
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su010_post_BCC_su010_post_SCC_su010_post_SCC_CD39_su010_pre_BCC_su010_pre_SCC_rep1_su010_pre_SCC_rep2",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of body",
                        "id": "UBERON:0002097"
                    },
                    "anatomic_site": "calf_ear",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 216,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+_CD45+CD3+CD8+CD39+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 40760,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su010"
        },
        {
            "repertoire_id": "su011_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su011",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "squamous cell carcinoma",
                            "id": "DOID:1749"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Radiation",
                        "immunogen": null,
                        "intervention": "Cemiplimab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su011_post_su011_pre_rep1_su011_pre_rep2",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of scalp",
                        "id": "UBERON:8300000"
                    },
                    "anatomic_site": "scalp",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 2913,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 15010,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su011"
        },
        {
            "repertoire_id": "su012_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su012",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "basal cell carcinoma",
                            "id": "DOID:2513"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Vismodegib",
                        "immunogen": null,
                        "intervention": "Cemiplimab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su012_post_su012_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of cheek",
                        "id": "UBERON:0008803"
                    },
                    "anatomic_site": "cheek",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 210,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 5932,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su012"
        },
        {
            "repertoire_id": "su013_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su013",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "squamous cell carcinoma",
                            "id": "DOID:1749"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Radiation, Cetuximab",
                        "immunogen": null,
                        "intervention": "Pembrolizumab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su013_post_su013_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of scalp",
                        "id": "UBERON:8300000"
                    },
                    "anatomic_site": "scalp",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 497,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 9080,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su013"
        },
        {
            "repertoire_id": "su014_PRJNA509910_TRB",
            "repertoire_name": null,
            "repertoire_description": null,
            "study": {
                "study_id": "PRJNA509910",
                "study_title": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
                "study_type": {
                    "label": "Study",
                    "id": "NCIT:C63536"
                },
                "study_description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
                "inclusion_exclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
                "grants": "This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R.K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists  from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research.",
                "study_contact": "Howard Y Chang, howchang@stanford.edu",
                "collected_by": "Howard Y Chang, howchang@stanford.edu",
                "lab_name": "Chang Lab, Center for Personal Dynamic Regulomes, Stanford University School of Medicine",
                "lab_address": "Stanford, CA, USA",
                "submitted_by": "Howard Y Chang, howchang@stanford.edu",
                "pub_ids": "DOI:10.1038/s41591-019-0522-3",
                "keywords_study": [
                    "contains_tr",
                    "contains_paired_chain",
                    "contains_schema_rearrangement",
                    "contains_schema_clone"
                ],
                "adc_publish_date": null,
                "adc_update_date": null
            },
            "subject": {
                "subject_id": "su014",
                "synthetic": false,
                "species": {
                    "label": "Homo sapiens",
                    "id": "NCBITAXON:9606"
                },
                "sex": null,
                "age_min": null,
                "age_max": 88,
                "age_unit": {
                    "label": "year",
                    "id": "UO:0000036"
                },
                "age_event": "sample collection",
                "ancestry_population": null,
                "ethnicity": null,
                "race": null,
                "strain_name": null,
                "linked_subjects": null,
                "link_type": null,
                "diagnosis": [
                    {
                        "study_group_description": "post treatment_pre treatment",
                        "disease_diagnosis": {
                            "label": "squamous cell carcinoma",
                            "id": "DOID:1749"
                        },
                        "disease_length": null,
                        "disease_stage": "advanced/metastatic",
                        "prior_therapies": "Radiation, Capecitabine",
                        "immunogen": null,
                        "intervention": "Cemiplimab",
                        "medical_history": null
                    }
                ],
                "genotype": null
            },
            "sample": [
                {
                    "sample_processing_id": null,
                    "sample_id": "su014_post_su014_pre",
                    "sample_type": "biopsy",
                    "tissue": {
                        "label": "skin of neck",
                        "id": "UBERON:0001417"
                    },
                    "anatomic_site": "neck",
                    "disease_state_sample": "advanced or metastatic",
                    "collection_time_point_relative": 280,
                    "collection_time_point_relative_unit": {
                        "label": "day",
                        "id": "UO:0000033"
                    },
                    "collection_time_point_reference": "post treatment_pre treatment",
                    "biomaterial_provider": "Stanford Hospital",
                    "tissue_processing": "Fresh tumor biopsies were minced and digested in 5 ml digestion medium (DMEM/F12 containing 250 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 liberase TL and 200 U ml\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u00991 DNase I) in a C-tube using the gentleMACS Octo system at 37 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 3 h at 20 r.p.m. Following digestion, 50 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of 500 mM EDTA was added and the sample was collected by centrifugation at 300g for 5 min. The cell suspension was then passed through a 70-\u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcm filter and pelleted by centrifugation at 300g at 4 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 10 min. Cells were then resuspended in 1 ml of RPMI 1640 medium and cryopreserved in fetal bovine serum supplemented with 10% dimethylsulfoxide until further processing.",
                    "cell_subset": {
                        "label": "T cell",
                        "id": "CL:0000084"
                    },
                    "cell_phenotype": "CD45+CD3+",
                    "cell_species": {
                        "label": null,
                        "id": null
                    },
                    "single_cell": true,
                    "cell_number": 6328,
                    "cells_per_reaction": 1,
                    "cell_storage": true,
                    "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcg/ml",
                    "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099) and malignant/stromal cells (CD45\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099CD3\u00c3\u0097\u00c2\u0092\u00c3\u008b\u00c2\u0086\u00c3\u00a2\u00c2\u0080\u00c2\u0099). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
                    "cell_processing_protocol": null,
                    "template_class": "RNA",
                    "template_quality": null,
                    "template_amount": null,
                    "template_amount_unit": {
                        "label": null,
                        "id": null
                    },
                    "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
                    "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturer\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0084\u00c2\u00a2s instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c800 cells per \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 500\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c7,000 cells, resulting in estimated multiplet rates of 0.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c5.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 13\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c18 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Amplified cDNA was then used for both 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u0082\u00c2\u00b2 gene expression library construction and TCR enrichment. For gene expression library construction, 2.4\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 14\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c16 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 \u00c3\u0096\u00c2\u00be\u00c3\u0082\u00c2\u00bcl of amplified cDNA by PCR (primer sets 1 and 2: 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 10 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 67 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min). Following TCR enrichment, 5\u00c3\u0097\u00c2\u0092\u00c3\u00a2\u00c2\u0082\u00c2\u00ac\u00c3\u00a2\u00c2\u0080\u00c2\u009c50 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 45 s; 9 cycles of 98 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s, 54 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 30 s, 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 20 s; 72 \u00c3\u0096\u00c2\u00b2\u00c3\u0082\u00c2\u00b0C for 1 min), and sizeselected with SPRIselect beads.",
                    "library_generation_kit_version": null,
                    "pcr_target": [
                        {
                            "pcr_target_locus": "TRB",
                            "forward_pcr_primer_target_location": null,
                            "reverse_pcr_primer_target_location": "TRBC, +52"
                        }
                    ],
                    "complete_sequences": "complete+untemplated",
                    "physical_linkage": "none",
                    "sequencing_run_id": null,
                    "total_reads_passing_qc_filter": null,
                    "sequencing_platform": "Illumina MiSeq or HiSeq 4000",
                    "sequencing_facility": null,
                    "sequencing_run_date": null,
                    "sequencing_kit": null,
                    "sequencing_files": {
                        "sequencing_data_id": null,
                        "file_type": "fastq",
                        "filename": null,
                        "read_direction": null,
                        "read_length": 150,
                        "paired_filename": null,
                        "paired_read_direction": null,
                        "paired_read_length": 150,
                        "index_filename": null,
                        "index_length": null
                    }
                }
            ],
            "data_processing": [
                {
                    "data_processing_id": null,
                    "primary_annotation": false,
                    "software_versions": null,
                    "paired_reads_assembly": null,
                    "quality_thresholds": null,
                    "primer_match_cutoffs": null,
                    "collapsing_method": null,
                    "data_processing_protocols": null,
                    "data_processing_files": [],
                    "germline_database": null,
                    "germline_set_ref": null,
                    "analysis_provenance_id": null,
                    "annotation": {
                        "aligner": {
                            "tool": "IgBLAST",
                            "version": "1.20.0"
                        },
                        "aligner_reference": {
                            "aligner_reference_v": "TRB  2022-05-16",
                            "aligner_reference_d": "TRB  2022-05-16",
                            "aligner_reference_j": "TRB  2022-05-16"
                        },
                        "Genotyper": {
                            "Tool": "TIgGER",
                            "Version": "1.2.0"
                        },
                        "Haplotyper": {
                            "Tool": "RAbHIT",
                            "Version": "0.2.0"
                        },
                        "Single Assignment": "true"
                    }
                }
            ],
            "combine_repertoire": "su014"
        }
    ]
}